Treatment of Recurrent Carcinoma of the Paranasal Sinuses Using Concomitant Infusion CIS-Platinum and Radiation Therapy

  • M. Rotman
  • K. Choi
  • S. Isaacson
  • J. Rosenthal
  • A. Braverman
  • J. Marti

Abstract

Radiotherapeutic control of squamous cell carcinoma extending to or destroying adjacent bone is unlikely without surgical resection. Successful treatment even with combined modality therapy is unlikely when tumor extends beyond the confines of the adjacent bone. Such is the case in advanced carcinomas of the paranasal sinuses. Unfortunately, paranasal sinus tumors often remain asymptomatic until advanced with an average delay of six months between the onset of symptoms and the start of treatment. (1)

Keywords

Toxicity Catheter Platinum Cobalt Pneumonia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harrison DFN: Problems in surgical management of neoplasms arising in the paranasal sinuses. J. Laryngol.90: 69, 1976.Google Scholar
  2. 2.
    B. Cummings, T. Keane, G. Thomas, A. Harwood, W. Rider, ‘Results and Toxicity of the Treatment of Anal Canal Carcinoma by Radiation Therapy or Radiation Therapy and Chemotherapy’, Cancer, 54:2062–2068 (1984).CrossRefGoogle Scholar
  3. 3.
    Glick JH, Zehngebot LM, Taylor SG IV: Chemotherapy for squamous cell carcinoma of the head and neck: a progress report. Am. J. Otolaryngol1: 306–323, 1980.CrossRefGoogle Scholar
  4. 4.
    Caradonna R, Paladine W, Ruckeschel JC, Goldstein JC, Olson JE, Jaski JW, Silvers SA, Hillinger S, Horton J: Methotrexate, bleomycin, and high-dose cis-dichlorodiam-mineplatinum (II) in the treatment of advanced epidermoid carcinoma of the head and neck. Cancer Treat Rep. 63: 489–491, 1979.Google Scholar
  5. 5.
    Vogl SE, Kaplan BH: Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin and cis-diamminedichloroplatinum (II) in an effective outpatient schedule. Cancer44: 26–31, 1979.CrossRefGoogle Scholar
  6. 6.
    Sato Y, Morita M, Takahashi H, Watanabe N, Kirikae I: Combined surgery, radiotherapy and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer25: 571–579, 1970.CrossRefGoogle Scholar
  7. 7.
    Cruz AB Jr, McLnnis WD, Aust JB: Triple drug intraarterial infusion combined with x-ray therapy and surgery for head and neck cancer. Am. J. Surg.128: 573–579, 1974.CrossRefGoogle Scholar
  8. 8.
    Zielke-Temme BC, Stevens KR Jr, Everts EC, Moseley HS, Ireland KM: Combined intraarterial chemotheapy, radiation therapy and surgery for advanced squamous cell carcinoma of the head and neck cancer. Cancer45: 1527–1532, 1980.CrossRefGoogle Scholar
  9. 9.
    Oberfield RA, Cady B, Booth JC: Regional arterial chemotherapy for advanced carcinoma of the head and neck. Cancer32: 82–88, 1973.CrossRefGoogle Scholar
  10. 10.
    Nervi C, Arcangeli G, Casale C, Cortese M, Guadangni A, LePera V: A reappraisal of intraarterial chemotherapy. Cancer26: 577–582, 1970.CrossRefGoogle Scholar
  11. 11.
    Shibuyatt et al.: Reappraisal of trimodal combination therapy for maxillary sinus carcinoma. Cancer50: 2790–2794, 1982.CrossRefGoogle Scholar
  12. 12.
    Parsons JT, Cassisi NJ, Million RR: Results of twice-a-day irradiation of squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys.10: 2041–2051, 1984.CrossRefGoogle Scholar
  13. 13.
    Wang CC: Twice daily radiation therapy for carcinoma of the head and neck (Abstr.). Int. J. Radiat. Oncol. Biol. Phys.7: 1261–1262, 1981.Google Scholar
  14. 14.
    Jaupolis S, Pipard G, Horiot JC, Bolla M, LeDorza C: Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck. Am. J. RoentgenolGoogle Scholar
  15. 15.
    Shukovsky ML, Fletcher GH: Time-dose and tumor volume relationships in the irradiation of squamous cell carcinoma of the tonsillar fossa. Radiology107: 621–626, 1973.Google Scholar
  16. 16.
    Withers HR: Response of tissue to multiple small dose fractions. Radiat. Res.71: 24, 1977.CrossRefGoogle Scholar
  17. 17.
    Shukovsky J, Fletcher GH, Montaque ED, Withers MD: Experience with twice-a-day fractionation in clinical radiotherapy. Vol 126, No 1 1976.Google Scholar
  18. 18.
    Heidelberger C, Greisbach L, Montag BJ, Mooren D, Cruz D, Schnitzer RJ, Grunberg E: Studies in fluorinated pyrimidines II. Effects on transplanted tumor. Ca Res. 18: 305–317, 1958.Google Scholar
  19. 19.
    Vermund H, Hodgett J, Ansfield FJG: Effects of combined roentgen irradiation and chemotherapy on transplanted tumors in mice. AJR85: 559–567, 1961.Google Scholar
  20. 20.
    Vietti J, Eggerding F, Valeriote F: Combined effect of x-radiation and 5 fluorouracil on survival of transplanted leukemic cells. J. Nat’l Ca Inst.47: 865–870, 1971.Google Scholar
  21. 21.
    Douple EB, Richmond RC: Platinum complexes as radio-sensitizers of hypoxic mammalian cells. Br. J. Cancer37, Suppl III, 98 - 102, 1978.Google Scholar
  22. 22.
    Douple EB, Richmond RC: A review of platinum complex biochemistry suggests a rationale for combined platinum-radiotherapy. Int. J. Radiat. Biol. Vol5: 1335–1339, 1979.Google Scholar
  23. 23.
    Salem PH et al.: Clinical phase I-II study of cis-dichlorodiammine- platinum (II) given by continuous I.V. infusion. Cancer Treatment Reports Vol. 62, No. 10, October 1978.Google Scholar
  24. 24.
    Creagen ET, Ingle JN, Schutt AJ, O’Fallon JR: A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms. Head and Neck Surgery6: 1020–1023, 1984.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • M. Rotman
    • 1
  • K. Choi
    • 1
  • S. Isaacson
    • 1
  • J. Rosenthal
    • 2
  • A. Braverman
    • 2
  • J. Marti
    • 3
  1. 1.Dept. of Radiation OncologySUNY, Downstate Medical CenterBrooklynUSA
  2. 2.Dept. of MedicineSUNY, Downstate Medical CenterBrooklynUSA
  3. 3.Dept. of SurgerySUNY, Downstate Medical CenterBrooklynUSA

Personalised recommendations